Ksilink is presenting a poster at this year’s International Congress of Parkinson’s Disease and Movement Disorders in Madrid, Spain.
If you are there, please come and discuss with Aurore Vuidel to learn more about our capacities to handle human dopaminergic neurons for the development of patient-based assays, ready for drug discovery purposes. All our assays go with tailored AI-powered image and data analysis tools, developed by our team. In Madrid, Aurore is illustrating our competencies by a disease model for Parkinson’s Disease, based on a mutation in LRRK2.
You can also have a look at the poster here.
Please do not hesitate to contact us to learn more.
